DE69823739D1 - Glycin zur Vorbeugung oder Behandlung von Transplantatabstossungen - Google Patents

Glycin zur Vorbeugung oder Behandlung von Transplantatabstossungen

Info

Publication number
DE69823739D1
DE69823739D1 DE69823739T DE69823739T DE69823739D1 DE 69823739 D1 DE69823739 D1 DE 69823739D1 DE 69823739 T DE69823739 T DE 69823739T DE 69823739 T DE69823739 T DE 69823739T DE 69823739 D1 DE69823739 D1 DE 69823739D1
Authority
DE
Germany
Prior art keywords
prevent
graft rejection
treat graft
glycine used
glycine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69823739T
Other languages
English (en)
Other versions
DE69823739T2 (de
Inventor
Heinz Schneider
Nigel Scott Cook
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Novartis Nutrition AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=25353479&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE69823739(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Novartis Nutrition AG filed Critical Novartis Nutrition AG
Publication of DE69823739D1 publication Critical patent/DE69823739D1/de
Application granted granted Critical
Publication of DE69823739T2 publication Critical patent/DE69823739T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Transplantation (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Solid-Sorbent Or Filter-Aiding Compositions (AREA)
  • Treatment Of Liquids With Adsorbents In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
DE69823739T 1997-06-05 1998-06-03 Glycin zur Vorbeugung oder Behandlung von Transplantatabstossungen Expired - Fee Related DE69823739T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US86939897A 1997-06-05 1997-06-05
US869398 1997-06-05

Publications (2)

Publication Number Publication Date
DE69823739D1 true DE69823739D1 (de) 2004-06-17
DE69823739T2 DE69823739T2 (de) 2005-04-28

Family

ID=25353479

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69823739T Expired - Fee Related DE69823739T2 (de) 1997-06-05 1998-06-03 Glycin zur Vorbeugung oder Behandlung von Transplantatabstossungen

Country Status (8)

Country Link
EP (1) EP0882451B1 (de)
JP (1) JPH1112170A (de)
AT (1) ATE266395T1 (de)
AU (1) AU711090B2 (de)
CA (1) CA2239582C (de)
DE (1) DE69823739T2 (de)
ES (1) ES2221095T3 (de)
ZA (1) ZA984825B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999062508A1 (en) * 1998-05-29 1999-12-09 Novartis Nutrition Ag A new use for glycine
ES2628590T3 (es) 2004-11-02 2017-08-03 Oragenics, Inc. Métodos para regular el peso y tamaño de los animales con glicina
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
CU20200012A7 (es) 2017-08-14 2021-02-04 Axcella Health Inc Composiciones de aminoácidos para el tratamiento de enfermedad hepática
MA52971A (fr) 2018-06-20 2021-04-28 Axcella Health Inc Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle
CN109758446A (zh) * 2019-03-22 2019-05-17 内蒙古自治区农牧业科学院 甘氨酸在作为奶山羊乳腺炎性应答的免疫调节剂中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5719133A (en) * 1994-09-21 1998-02-17 Novartis Nutrition Ag Adolescent dietary composition
KR19980702436A (ko) * 1995-02-23 1998-07-15 하인쯔 쉬나이더, 미첼 오르진거 아미노산 조성물 및 임상용 영양물내에 이의 사용 방법
US6096785A (en) * 1996-07-30 2000-08-01 Novartis Nutrition Ag Amino acid compositions and use thereof in treating renal dysfunction
WO1998004255A1 (en) * 1996-07-30 1998-02-05 Novartis Nutrition Ag Amino acid composition and use thereof in treating tumor growth and metastasis

Also Published As

Publication number Publication date
JPH1112170A (ja) 1999-01-19
CA2239582C (en) 2008-04-22
ZA984825B (en) 1998-12-07
DE69823739T2 (de) 2005-04-28
AU6989998A (en) 1998-12-10
ES2221095T3 (es) 2004-12-16
ATE266395T1 (de) 2004-05-15
AU711090B2 (en) 1999-10-07
EP0882451B1 (de) 2004-05-12
EP0882451A1 (de) 1998-12-09
CA2239582A1 (en) 1998-12-05

Similar Documents

Publication Publication Date Title
TR199501053A2 (tr) Tedavide yararli spiro-azabisiklik bilesikler.
DE68904598D1 (de) Abwasserbehandlungsverfahren.
DE3884622D1 (de) Schmiermittelzubereitung zur behandlung von rheuma.
DE69427869D1 (de) Botulinumtoxine zur behandlung von hyperhydrosis
DE3483040D1 (de) Maschinelesbares dokument und dessen behandlung.
BG96705A (bg) Метод за пречистване на отпадъчни води
TR200000374T2 (tr) Akut akciğer harabiyeti ve fibrozitinin alfavbeta6 antagonistleriyle tedavisi.
ATE133564T1 (de) Flupirtin in kombination mit antiparkinsonika zur bekämpfung von muskelverspannungen
DE68908418D1 (de) Gurt zur speicherung von elektronischen bauelementen.
DE3670776D1 (de) System und zentrifugaloxygenator zur klaerung von abwasser.
DE69823739D1 (de) Glycin zur Vorbeugung oder Behandlung von Transplantatabstossungen
ATE53302T1 (de) Mittel zur behandlung von wunden.
DE69827545D1 (de) Vorrichtung zur Erzeugung von Hintergrundrauschen
ZA978129B (en) Method of treating leather with improved retanning agents.
DK67683A (da) Fremgangsmaade til fremstilling af 2,3-diaryl-5-halogen-thio-phener
DE69626816D1 (de) Verwendung von selegilin zur behandlung von gehörverlust bei säugetieren
ES2147440T3 (es) Bandeja, especialmente bandeja de servir.
DE69818809D1 (de) Verfahren zur behandlung von narbengewebe
DE69111324D1 (de) Vorrichtung zur Behandlung oder Trennung von Gasen.
DE69011871D1 (de) In-line-geräuschdämpfungsvorrichtung.
DE68907569D1 (de) Mittel zur behandlung oder vorbeugung von aids.
ES1034119Y (es) Cinturon de seguridad de duchas y baño.
DE59105421D1 (de) Mikrobiologische Oxidation von Ethylgruppen in Heterocyclen.
DE69712287D1 (de) Verwendung von Sulbutiamin zur Behandlung von psychomotorischen oder psychointellektuellen Beschwerden
DE69114853D1 (de) Abwasserbehandlung.

Legal Events

Date Code Title Description
8327 Change in the person/name/address of the patent owner

Owner name: NOVARTIS AG, BASEL, CH

8363 Opposition against the patent
8365 Fully valid after opposition proceedings
8339 Ceased/non-payment of the annual fee